- 英文名称
- Yangambin
- 分子式
- C24H30O8
- 分子量
- 446.49
- 中文别名
- (1S,3aR,4S,6aR)-1,4-双(3,4,5-三甲氧基苯基)四氢-1H,3H-呋喃并[3,4-c]呋喃; O,O-二甲基鹅掌楸树脂醇 B; 丁香树脂二甲醚; 鹅掌楸树酯酚B二甲醚; 杨木脂素; (1S,3aR,4S,6aR)-1,4-Bis(3,4,5-trimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan; (3S,3aR,6S,6aR)-3,6-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; Lirioresinol B dimethyl ether; Lirioresinol B,O,O-dimethyl; syringaresinol dimethyl ether; Lirioresinol B,dimethyl; O,O-Dimethyllirioresinol B; (+)-Yangambin; Yangabin; (+)-Yangabin; (+)-O,O-Dimethyllirioresinol B; Dimethyllirioresinol; lirioresinol B dimethylether; Lirioresinol-B dimethyl ether; lirioresinol-B-dimethyl ether; (+)-syringaresinol dimethyl ether; Lrioresinol B dimethyl ether; (1S,3aR,4S,6aR)-Tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-1H,3H-furo[3,4-c]furan; (1S)-1β,4β-Bis(3,4,5-trimethoxyphenyl)-3aβ,4,6,6aβ-tetrahydro-1H,3H-furo[3,4-c]furan
- 用途
- 生命科学；中草药成分，有逐水祛痰、破积杀虫之功效；临床用于肌、骨、脉“奇哈”症，丹毒、乳痈、腮肿(腮腺炎)、黄水疮、痘疮；作为选择性PAF受体拮抗剂，有抗过敏（β-氨基己糖苷酶IC50 33.8 μM）、抗炎（IC50 37.4 μM）活性，可调控Ca²⁺通道。
